Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-choline PET-CT assessment of cabazitaxel response in metastatic castration-resistant prostate cancer
NL-OMON20481Recruiting
- Sponsor
- VU University Medical Center
- Start
- Sep 2017
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cabazitaxel in prostate cancer (PCa), sponsored by VU University Medical Center. Started Sep 2017; status: recruiting.
02
Drugs
cabazitaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON20481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20481.